NCI-Frederick November events

I lifted this table off NCI-Frederick’s web site and included it as a new link on the Calendar page:

Tuesday, November 06, 2007
8:30:00 AM	Michael Dean, PhD	Bldg 549 Conf. Rm B
	Cancer, Inflammation, and Stem Cells	Details Series
Wednesday, November 07, 2007
12:00:00 PM	Sina Bavari	Bldg 549 Auditorium
	Innate Immune Responses to Highly Pathogenic Microbes	Details Series
Friday, November 09, 2007
12:00:00 PM	Dr. Hal Broxmeyer	Bldg 549 Auditorium
	Regulation of Hematopoietic and Embryonic Stem Cells	Details Series
Tuesday, November 13, 2007
8:30:00 AM	Jacques Banchereau, PhD	Bldg 549 Conf. Rm B
	Harnessing Dendritic Cells to Build Cancer Vaccines	Details Series
Wednesday, November 14, 2007
12:00:00 PM	James Kelley	Bldg 549 Auditorium
	Getting a Charge Out of Chemistry: Making and Using Ions for Bioanalysis	Details Series
Friday, November 16, 2007
11:00:00 AM	Dr. Joseph Lakowicz, Director	Bldg 549 Auditorium
	Plasmon-Controlled Fluorescence: A New Paradigm in Biological Fluorescence	Details Series
12:00:00 PM	Dr. Licia Selleri	Bldg 426 Conf. Rm
	A First Step Towards a Genetic and Transcriptional Control of Spleen Development	Details Series
Tuesday, November 20, 2007
8:30:00 AM	Ian F. Tannock, MD, PhD,FRCPC	Bldg 549 Conf. Rm B
	Limited Drug Distribution and Repopulation as Important and Neglected Causes of Drug Resistance in Solid Tumors	Details Series
Tuesday, November 27, 2007
8:30:00 AM	Catherine M. Handy, PhD, RN, AOCN	Bldg 549 Conf. Rm B
	The Future is Bright Yet so Small: Nanotechnology and Cancer Therapy	Details Series
Wednesday, November 28, 2007
12:00:00 PM	Steven Hou	Bldg 549 Auditorium
	Molecular Genetic Study of Stem Cell Regulation in Drosophila and Mice	Details Series
Thursday, November 29, 2007
9:00:00 AM	Various Speakers	Bldg 10 Lipsett
	The IL-10 Cytokine Family: IL-10, IL-19, IL-20, IL-24 and IL-28/IL-29	Details
Friday, November 30, 2007
12:00:00 PM	Dr. William Paul	Bldg 549 Auditorium
	The2 Cells: Differentiation and Repertoire-dependent Immunopathology	Details Series

I think that these would be open to the public, but am awaiting verification from someone at NCI. This is the type of information I’ve been looking for that would benefit everyone in the Frederick County Biotech community. I was delighted and surprised to see Dr Harold Broxmeyer speaking 11/9. He is a giant in the field of hematopoeitic stem cell research and transplantation.

Invitrogen Announces Third Quarter 2007 Results

I was surprised to hear that Invitrogen had “turned things around” and pulled out of a major slide. That’s my take, this is the Washington Post’s more sterile version:

CARLSBAD, Calif., Oct 30, 2007 (BUSINESS WIRE) — Invitrogen Corporation (IVGN) today announced results for its third quarter ended September 30, 2007. Revenues for the third quarter were $315 million, an increase of 11 percent over the $284 million for 2006, excluding the impact of discontinued operations.

“We’re pleased our work to achieve balanced growth across all products and regions and return margins to historical levels is paying off sooner than expected,” said Greg Lucier, Chairman and Chief Executive Officer of Invitrogen. “Our focus from here is to sustain and expand upon these results by driving further sales penetration in high growth regions, targeted investments in breakthrough technologies and broader implementation of our reagent productivity strategies.”

“Return margins to historical levels”? I wonder if he’s referring to before Invitrogen came into town and screwed everything up and lost 1/2 of LTI’s old customer base? Now if they would just start working on restoring product quality and Customer service to “historical levels” they might start to win back a few customers in Frederick County.